Published Literature

The Lancet

Click here to read the latest research published in The Lancet. Selected publications have been listed below. Please click on the titles to access the PDF version.

1) Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, Liu X, Wei L, Truelove SA, Zhang T, Gao W. Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts. Lancet Infect Dis. 2020 Mar 30. pii: S1473-3099(20)30243-7. doi: 10.1016/S1473-3099(20)30243-7. [Epub ahead of print]

2) Ayebare RR, Flick R, Okware S, Bodo B, Lamorde M. Adoption of COVID-19 triage strategies for low-income settings. The Lancet Respiratory Medicine. 2020 Apr 1;8(4):e22.

3) Thanh HN, Van TN, Thu HN, Van BN, Thanh BD, Thu HP, Kieu AN, Viet NN, Marks GB, Fox GJ, Nguyen TA. Outbreak investigation for COVID-19 in northern Vietnam. The Lancet Infectious Diseases. 2020 Mar 4.

4) Petherick A. Developing antibody tests for SARS-CoV-2. The Lancet. 2020 Apr 4;395(10230):1101-2.

5) To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, Lau DP. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases. 2020 Mar 23.

6) First experience of COVID-19 screening of health-care workers in England.

Hunter E, Price DA, Murphy E, van der Loeff IS, Baker KF, Lendrem D, Lendrem C, Schmid ML, Pareja-Cebrian L, Welch A, Payne BAI, Duncan CJA.Lancet. 2020 Apr 22:S0140-6736(20)30970-3. doi: 10.1016/S0140-6736(20)30970-3

Nature

Click here to read the latest research published in Nature. The Nature publishing house wades through the literature on COVID-19 so you don’t have to.

1) Leung, N.H.L., Chu, D.K.W., Shiu, E.Y.C. et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med (2020). https://doi.org/10.1038/s41591-020-0843-2

2) Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47

New England Journal of Medicine

Click here to read the latest research published in NEJM. 

1) J. Grein, N. Ohmagari, D. Shin, G. Diaz, E. Asperges, A. Castagna, T. Feldt,G. Green, M.L. Green, F.-X. Lescure, E. Nicastri, R. Oda, K. Yo, E. Quiros‑Roldan, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020 Apr 10. doi: 10.1056/NEJMoa2007016. [Epub ahead of print]

2) van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine. 2020 Mar 17.

3) McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, Lewis J, Baer A, Kawakami V, Lukoff MD, Ferro J. Epidemiology of COVID-19 in a long-term care facility in King County, Washington. New England Journal of Medicine. 2020 Mar 27.

4) Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KS, Lau EH, Wong JY, Xing X. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine. 2020 Jan 29.

Journal of the American Medical Association

Click here to read the latest research published in NEJM. 

1) Giacomo Grasselli, MD; Alberto Zangrillo, MD; Alberto Zanella, MD; Massimo Antonelli, MD; Luca Cabrini, MD; Antonio Castelli, MD; Danilo Cereda, MD; Antonio Coluccello, MD; Giuseppe Foti, MD; Roberto Fumagalli, MD; Giorgio Iotti, MD; Nicola Latronico, MD; Luca Lorini, MD; Stefano Merler, MS; Giuseppe Natalini, MD; Alessandra Piatti, MD; Marco Vito Ranieri, MD; Anna Mara Scandroglio, MD; Enrico Storti, MD; Maurizio Cecconi, MD; Antonio Pesenti, MD.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA. 2020 Apr 6. doi: 10.1001/jama.2020.5394. [Epub ahead of print]

2) James M. Sanders; Marguerite L. Monogue; Tomasz Z. Jodlowski; James B. Cutrell, Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. Published online April 13, 2020. doi:10.1001/jama.2020.6019

3) Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. Jama. 2020 Jan 1.

Cell

Click here to read the latest research published in The Cell.

1) Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 Mar 5.

2) Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Mar 9.

3) Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.

Monteil V, Kwon H, Prado P, Hagelkrüys A, Wimmer RA, Stahl M, Leopoldi A, Garreta E, Hurtado Del Pozo C, Prosper F, Romero JP, Wirnsberger G, Zhang H, Slutsky AS, Conder R, Montserrat N, Mirazimi A, Penninger JM.Cell. 2020 Apr 17:S0092-8674(20)30399-8. doi: 10.1016/j.cell.2020.04.004.

Other Journals

1) Wen F, Yu H, Guo J, Li Y, Luo K, Huang S. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2. Journal of Infection. 2020 Mar 5.

2) Zhang J, Jia W, Zhu J, Li B, Xing J, Liao M, Qi W. Insights into the cross-species evolution of 2019 novel coronavirus. Journal of Infection. 2020 Jan 1.

3) Wang LS, Wang YR, Ye DW, Liu QQ. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. International Journal of Antimicrobial Agents. 2020 Mar 19:105948.

4) Zhang X, Cai H, Hu J, Lian J, Gu J, Zhang S, Ye C, Lu Y, Jin C, Yu G, Jia H. Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. International Journal of Infectious Diseases. 2020 Mar 20.

5) Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine. 2020 Mar 10.

6) COVID C, COVID C, COVID C, Chow N, Fleming-Dutra K, Gierke R, Hall A, Hughes M, Pilishvili T, Ritchey M, Roguski K. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019—United States, February 12–March 28, 2020. Morbidity and Mortality Weekly Report. 2020 Apr 3;69(13):382.

7) Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, Qian S. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clinical Infectious Diseases. 2020 Jan 1.

8) Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, Zhang L. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clinical Infectious Diseases. 2020 Mar 21.

9) Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, Sun R, Wang Y, Hu B, Chen W, Zhang Y. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. Journal of medical virology. 2020 Feb 27.

10) Society for Advanced Bronchoscopy Consensus Statement and Guidelines for bronchoscopy and airway management amid the COVID-19 pandemic.

Michael A. Pritchett, Catherine L. Oberg, Adam Belanger, Jose De Cardenas, George Cheng, Gustavo Cumbo Nacheli, Carlos Franco-Paredes, Jaspal Singh, Jennifer Toth, Michael Zgoda, Erik Folch. J Thorac Dis 2020 | http://dx.doi.org/10.21037/jtd.2020.04.32 

11) Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting.

Wang M, Hu Z. Virologica Sinica. 2013 Dec 1;28(6):315-7.

12) Prevalence and Characteristics of Gastrointestinal Symptoms in Patients with SARS-CoV-2 Infection in the United States: A Multicenter Cohort Study.

Redd WD, Zhou JC, Hathorn KE, McCarty TR, Bazarbashi AN, Thompson CC, Shen L, Chan WW.Gastroenterology. 2020 Apr 22:S0016-5085(20)30564-3. doi: 10.1053/j.gastro.2020.04.045. 

13) Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery.

Parhar HS, Tasche K, Brody RM, Weinstein GS, O'Malley BW Jr, Shanti RM, Newman JG. Head Neck. 2020 Apr 25. doi: 10.1002/hed.26200. Online ahead of print.

14) Point-of-Care Lung Ultrasound Findings in Patients with Novel Coronavirus Disease (COVID-19) Pneumonia.

Yasukawa K, Minami T.Am J Trop Med Hyg. 2020 Apr 24. doi: 10.4269/ajtmh.20-0280.

15) The role of extracorporeal life support for patients with COVID-19: Preliminary results from a statewide experience.

Sultan I, Habertheuer A, Usman AA, Kilic A, Gnall E, Friscia ME, Zubkus D, Hirose H, Sanchez P, Okusanya O, Szeto WY, Gutsche J.J Card Surg. 2020 Apr 25. doi: 10.1111/jocs.14583.

16) A hypothesis for pathobiology and treatment of COVID-19: the centrality of ACE1/ACE2 imbalance.

Sriram K, Insel PA.Br J Pharmacol. 2020 Apr 24. doi: 10.1111/bph.15082

17) Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.

Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE, Boolbol SK, Anderson BO, Shulman LN, Gradishar WJ, Monticciolo DL, Plecha DM, Nelson H, Yao KA.Breast Cancer Res Treat. 2020 Apr 24. doi: 10.1007/s10549-020-05644-z.

 

18) Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic.

Shen Q, Wang M, Che R, Li Q, Zhou J, Wang F, Shen Y, Ding J, Huang S, Yap HK, Warady BA, Xu H, Zhang A; Chinese Society of Pediatric Nephrology and Chinese Medical Doctor Association of Pediatric Nephrology.Pediatr Nephrol. 2020 Apr 24. doi: 10.1007/s00467-020-04555-x

 

19) COVID-19 in persons with haematological cancers.

He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP.Leukemia. 2020 Apr 24. doi: 10.1038/s41375-020-0836-7. 

 

20) Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, Barrelet A, Chauvet C, Chazal T, Delahousse M, Devaux M, Euvrard R, Fadlallah J, Florens N, Haroche J, Hié M, Juillard L, Lhote R, Maillet T, Richard-Colmant G, Palluy JB, Pha M, Perard L, Remy P, Rivière E, Sène D, Sève P, Morélot-Panzini C, Viallard JF, Virot JS, Benameur N, Zahr N, Yssel H, Godeau B, Amoura Z.Ann Rheum Dis. 2020 Apr 24:annrheumdis-2020-217566. doi: 10.1136/annrheumdis-2020-217566.

 

21) Guidelines of clinical practice for the management of swallowing disorders and recent dysphonia in the context of the COVID-19 pandemic.

Mattei A, Amy de la Bretèque B, Crestani S, Crevier-Buchman L, Galant C, Hans S, Julien-Laferrière A, Lagier A, Lobryeau C, Marmouset F, Robert D, Woisard V, Giovanni A; French Society of Otorhinolaryngology, Head, Neck Surgery (SFORL); French Society of Phoniatrics, Laryngology (SFPL).Eur Ann Otorhinolaryngol Head Neck Dis. 2020 Apr 20:S1879-7296(20)30101-0. doi: 10.1016/j.anorl.2020.04.011.

 

 

22) Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis.

Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I, Antariksa B.Am J Emerg Med. 2020 Apr 19:S0735-6757(20)30280-1. doi: 10.1016/j.ajem.2020.04.052.

 

23) Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy.

Piva S, Filippini M, Turla F, Cattaneo S, Margola A, De Fulviis S, Nardiello I, Beretta A, Ferrari L, Trotta R, Erbici G, Focà E, Castelli F, Rasulo F, Lanspa MJ, Latronico N.J Crit Care. 2020 Apr 14;58:29-33. doi: 10.1016/j.jcrc.2020.04.004.

 

24) Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain).

Rodríguez-Lago I, Ramírez de la Piscina P, Elorza A, Merino O, Ortiz de Zárate J, Cabriada JL.Gastroenterology. 2020 Apr 21:S0016-5085(20)30560-6. doi: 10.1053/j.gastro.2020.04.043

 

25) The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy.

Maggi U, De Carlis L, Yiu D, Colledan M, Regalia E, Rossi G, Angrisani M, Consonni D, Fornoni G, Piccolo G, DeFeo TM.Am J Transplant. 2020 Apr 24. doi: 10.1111/ajt.15948

 

26) COVID-19 in Solid Organ Transplant Recipients: Initial Report from the US Epicenter.

Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, Arcasoy S, Aversa MM, Benvenuto LJ, Dadhani D, Kapur S, Dove LM, Brown RS, Rosenblatt RE, Samstein B, Uriel N, Farr MA, Satlin M, Small CB, Walsh T, Kodiyanplakkal RP, Miko BA, Aaron JG, Tsapepas DS, Emond JC, Verna EC.Am J Transplant. 2020 Apr 24. doi: 10.1111/ajt.15941

 

27) SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.

Lu X, Xiang Y, Du H, Wing-Kin Wong G.Pediatr Allergy Immunol. 2020 Apr 24. doi: 10.1111/pai.13267. 

 

28) Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission.

Lu D, Sang L, Du S, Li T, Chang Y, Yang XA.J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25927.

 

29) Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.

Jiang X, Luo M, Zou Z, Wang X, Chen C, Qiu J.J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25941

30) SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.

Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, Gao Z.J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25936

© 2020 by Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS)

For queries regarding this website, please e-mail to Faculty Incharge at molmed.pgi.covid@gmail.com